SCHEMBL22332833

SCHEMBL22332833

COCCCc1nnc(NS(=O)(=O)C(C)C(C)c2ncc(F)cn2)n1-c1c(OC)cccc1OC

nearest known ligand 0.81

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
APLNR P35414 20/20 0.81

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20168417 0.89 APLNR (1.00) APLNR
SCHEMBL20168419 0.89 APLNR (1.00) APLNR
SCHEMBL20166491 0.87 APLNR (1.00) APLNR
SCHEMBL20166492 0.87 APLNR (1.00) APLNR
SCHEMBL20179534 0.85 APLNR (1.00) APLNR
SCHEMBL20179533 0.85 APLNR (1.00) APLNR
SCHEMBL20168124 0.84 APLNR (1.00) APLNR
SCHEMBL20168123 0.84 APLNR (1.00) APLNR
SCHEMBL22332915 0.84 APLNR (0.84) APLNR
SCHEMBL19573920 0.82 APLNR (0.81) APLNR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3452466-B1 HETEROCYCLIC TRIAZOLE COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR AMGEN INC (US) 2020-08-12 EP disclosed